Plaque Psoriasis
The most common form of psoriasis; it presents with well-defined, thickened plaques topped by silvery scale on the elbows, knees and trunk, often with itch.
Clinic and treatment images
Tap to enlargeDo you recognise these signs?
If one or more of these applies to you, we recommend a dermatological assessment.
- Sharply demarcated, thickened red plaques on the elbows, knees and lower back
- A silvery-white, loosely adherent scale covering the surface of each plaque
- Itch, tightness and pinpoint bleeding points when the scale is scratched off
- Persistent, recurring sites along the hairline, the navel and the natal cleft
Causes and triggers
- An immune-driven process that renews the skin cells far too quickly
- A familial predisposition and specific genetic background that raise the risk
- Stress, smoking, alcohol and cold, dry weather that provoke the flare-ups
- Skin trauma, infection and certain medicines that seed fresh new plaques
How we treat it
Reducing plaque thickness and scale with a cortisone-free topical regimen
Strengthening the skin with ceramide barrier repair and regular moisturising
NB-UVB phototherapy for widespread disease; 2–3 sessions weekly, 20–30 per course
Systemic or biologic agents for resistant disease, tracked with PASI and DLQI
Why Clinovia?
Psoriasis and eczema are not only a surface problem. We assess the skin barrier, inflammation, nutrition and lifestyle, comorbidities and dermatological treatment together. Evidence-based dermatology remains the backbone; nutrition and lifestyle support that plan.
The Gut–Skin Relationship
We review digestive symptoms, dietary pattern and food-sensitivity history. The link between gut microbiome and inflammatory skin disease is still being researched, so it is addressed alongside — never instead of — dermatological treatment.
Cortisone-Free Protocol
First-line calcineurin and PDE-4 inhibitors, ceramide-based barrier repair and phototherapy instead of steroids; systemic and biologic steps when needed.
Systemic Repair
Vitamin D, zinc, omega-3 and iron levels plus thyroid and insulin resistance are screened, and any deficits found are built into the plan.
Measurable Follow-up
PASI/EASI and DLQI scores are tracked alongside laboratory values; steps that do not deliver a response are removed from the plan.
No. Psoriasis is not contagious; it does not spread through contact, swimming pools or shared items. It is an immune-mediated skin condition with an inherited background. The aim of treatment is to bring the plaques under control, ease the itch and make flare-ups less frequent.
For most patients, yes. At our centre we build a cortisone-free plan using calcineurin inhibitors, PDE-4 inhibitors, ceramide barrier care and NB-UVB phototherapy when needed. Widespread or resistant disease is assessed for systemic and biologic options, with progress measured by PASI and DLQI.
Yes. For infant eczema and paediatric psoriasis we use age-appropriate topical stepping, a moisturising routine and, when indicated, paediatric phototherapy dosing.
Our standard protocols are cortisone-free. We work with topical calcineurin inhibitors, PDE-4 inhibitors, ceramide-based barrier repair, NB-UVB phototherapy and biologic agents when needed. Cortisone is considered only for very short, unavoidable situations and with the patient's consent.
Other conditions
Guttate PsoriasisAn abrupt-onset form that often follows a throat infection, marked by numerous small, teardrop-shaped, lightly scaled plaques scattered across the trunk and arms.
Learn more
Scalp PsoriasisA stubborn form affecting the scalp, hairline and area behind the ears with thick, adherent scale; it often itches and can cause temporary hair shedding.
Learn more
Nail PsoriasisAffecting finger and toe nails with pitting, discolouration, thickening and separation from the nail bed; it responds slowly and calls for patience and steady care.
Learn more
NB-UVB PhototherapyNarrowband UVB at 311 nm calms inflammation in psoriasis and eczema without cortisone. Sessions run two to three times a week, with a typical course of 20–30 and PASI/EASI tracking.
Learn more
Biologic TreatmentsBiologic drugs selectively block targets such as IL-17 and IL-23 in psoriasis and IL-4/13 in eczema. They are considered in moderate-to-severe, resistant disease after screening.
Learn more
Systemic TherapySystemic drugs such as methotrexate, cyclosporine and acitretin are used in widespread or resistant psoriasis and eczema, alongside laboratory and safety monitoring.
Learn more
Let's build the right plan for your skin today
Fill in the form and our coordinator will call you the same day to arrange the right doctor and time slot.
- Same-day callback
- Consultation in five languages
- Written treatment plan
- Defterdar, Fethi Çelebi Cd. No:15, 34050 Eyüpsultan/İstanbul, Türkiye
- Mon–Sat: 09:00 – 19:00